GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Haiyao Co Ltd (SZSE:000566) » Definitions » Debt-to-EBITDA

Hainan Haiyao Co (SZSE:000566) Debt-to-EBITDA : 42.97 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Hainan Haiyao Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Hainan Haiyao Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,225 Mil. Hainan Haiyao Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥834 Mil. Hainan Haiyao Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ¥71 Mil. Hainan Haiyao Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 42.97.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Hainan Haiyao Co's Debt-to-EBITDA or its related term are showing as below:

SZSE:000566' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -23.46   Med: 6.16   Max: 103.71
Current: 103.71

During the past 13 years, the highest Debt-to-EBITDA Ratio of Hainan Haiyao Co was 103.71. The lowest was -23.46. And the median was 6.16.

SZSE:000566's Debt-to-EBITDA is ranked worse than
99.09% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs SZSE:000566: 103.71

Hainan Haiyao Co Debt-to-EBITDA Historical Data

The historical data trend for Hainan Haiyao Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Haiyao Co Debt-to-EBITDA Chart

Hainan Haiyao Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.87 -23.46 -2.90 10.87 15.40

Hainan Haiyao Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.13 22.57 -348.29 -29.89 42.97

Competitive Comparison of Hainan Haiyao Co's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Haiyao Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Haiyao Co's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Haiyao Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hainan Haiyao Co's Debt-to-EBITDA falls into.



Hainan Haiyao Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Hainan Haiyao Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2460.363 + 902.448) / 218.351
=15.40

Hainan Haiyao Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2224.779 + 833.895) / 71.18
=42.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Hainan Haiyao Co  (SZSE:000566) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Hainan Haiyao Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hainan Haiyao Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Haiyao Co (SZSE:000566) Business Description

Traded in Other Exchanges
N/A
Address
No.192 Nanhai Avenue, Xiuying District, Haikou, Hainan, CHN, 570105
Hainan Haiyao Co Ltd is a China-based company engages in the research, development, manufacture, and sale of medicines and medical instrument. Its product includes cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The company distributes its products in domestic market and to overseas market. Digital China Information Service Co Ltd is a China-based company principally engaged in software and information technology (IT) service industry. Its services include technical services, agricultural informatization, application software development, special financial equipment, and integrated solutions for the financial, government, enterprises, telecommunications, agriculture, and other industries.
Executives
Li Ri Meng Directors, executives
Bai Zhi Quan Directors, executives
Zhou Qing Guo Supervisors
Chen Yi Hong Directors, executives
Wang Wei Directors, executives
Ji Ping Executives
Xu Li Hong Directors, executives
Zhang Hui Executives
Wang Jun Hong Executives
Li Mi Sheng Executives
Feng Bai Chang Executives
Wang Gang Executives
Ceng Yu Ping Director

Hainan Haiyao Co (SZSE:000566) Headlines

No Headlines